CarlsonMG. Cerebral Palsy. In: GreenD.P.H.R.P.W.W.S, editor. Green's operative hand surgery. 5th ed.Philadelphia: Churchill Livingstone; 2005. p. 1197–234.
2.
CarrollRECraigFS. The surgical treatment of cerebral palsy. Surg Clin North Am.1951;30:385–96.
3.
GoldnerJL. Reconstructive surgery of the hand in cerebral palsy and spastic paralysis resulting from injury to the spinal cord. J Bone Joint Surg.1955;37A(6):1141–55.
4.
GoldnerJL. Upper extremity tendon transfers in cerebral palsy. Orthop Clin North Am.1974;5:389–414.
5.
GreenWT. Ten transplantation of the flexor carpi ulnaris for pronation-flexion deformity of the wrist. Surg Gynecol Obstet.1942;75(1):337–42.
6.
GreenWTBanksHH. Flexor carpi ulnaris transplant and its use in cerebral palsy. J Bone Joint Surg.1962;44A(7):1343–52.
7.
KomanLAGelbermanRHTobyBEPoehlingGG. Cerebral palsy; management of the upper extremity. Clin Orthop.1990;253:62–74.
8.
LandiACavazzaSCasertaGLetiAASartiniSGaglianoMC. The upper limb in cerebral palsy: surgical management of shoulder and elbow deformities. Hand Clin.2003;19(4):631–48.
9.
ManskePRLangewischKRStreckerWBAlbrechtMM. Anterior elbow release of spastic elbow flexion deformity in children with cerebral palsy. J Pediatr Orthop.2001;21(6):772–7.
10.
SzaboRMGelbermanRH. Operative treatment of cerebral palsy. Hand Clin.1985;1:525–43.
11.
Van HeestAHouseJHCarielloC. Upper extremity surgical treatment of cerebral palsy. J Hand Surg.1999;24A:323–30.
12.
ZancolliEAZancolliERJr. Surgical management of the hemiplegic spastic hand in cerebral palsy. Surg Clin North Am.1981;61(2):395–406.
13.
CorryISCosgroveAPDuffyCM. Botulinum toxin A as an alternative to serial casting in the conservative management of equinus in cerebral palsy. Dev Med Child Neurol.1995;37:20–1.
14.
FehlingsDRangMGlazierJSteeleC. An evaluation of botulinum-A toxin injections to improve upper extremity function in children with hemiplegic cerebral palsy. J Pediatr.2000;137(3):331–7.
15.
FehlingsDNovakIBerweckSHoareBStottNSRussoRN. Botulinum toxin assessment, intervention and follow-up for paediatric upper limb hypertonicity: international consensus statement. Eur J Neurol.2010;17 Suppl 2:38–56.
16.
KomanLAMooneyJFSmithBGoodmanAMulvaneyT. Management of cerebral palsy with botulinum-A toxin: preliminary investigation. J Pediatr Orthop.1993;13(4):489–95.
17.
KomanLASmithBPWilliamsRRichardsonRNaughtonMGriffinL. Upper extremity spasticity in children with cerebral palsy: a randomized, double-blind, placebo-controlled study of the short-term outcomes of treatment with botulinum A toxin. J Hand Surg Am.2013;38(3):435–46.
18.
Clayton-JonesE. Annual meeting of the American Academy for Cerebral Palsy. Dev Med Child Neurol.1965;7(5):84–92.
19.
HouseJHGwathmeyFWFidlerMO. A dynamic approach to the thumb-in-palm deformity in cerebral palsy. J Bone Joint Surg.1981;63A:216–25.
20.
World Health Organization. The international classificatin of functioning, disabiilty and health (ICF). Geneva: World Health Organization; 2001.
21.
JohnsonLMRandallMJReddihoughDSOkeLEByrtTABachTM. Development of a clinical assessment of quality of movement for unilateral upper-limb function. Dev Med Child Neurol.1994;36(11):965–73.
22.
RandallMCarlinJBChondrosPReddihoughD. Reliability of the Melbourne assessment of unilateral upper limb function. Dev Med Child Neurol.2001;43:761–7.
23.
AshworthB. Preliminary trial of carisoprodol in multiple sclerosis. Practitioner.1964;192:540–2.
24.
BohannonRWSmithMB. Interrater reliability of a modified Ashworth scale of muscle spasticity. Phys Ther.1987;67:206–7.
25.
TardieuGShentoubSDelarueR. A la Recherche d'une technique de mesure de la spasticite. Neurologique.1954;91:143–4.
26.
KomanLAWilliamsRMEvansPJRichardsonRNaughtonMJPassmoreL. Quantification of upper extremity function and range of motion in children with cerebral palsy. Dev Med Child Neurol.2008;50(12):910–7.
27.
BoyceWFGowlandCRosenbaumPLLaneMPlewsNGoldsmithCH. The gross motor performance measure: validity and responsiveness of a measure of quality of movement. Phys Ther.1995;75:603–13.
28.
DavidoffRA. Antispasticity drugs: mechanisms of action. Ann Neurol.1985;17(2):107–16.
29.
WagstaffABrysonHM. Tizanidine: a review of its pharmacology, clinical efficacy and tolerability in the management of spasticity associated with cerebral and spinal disorders. Drugs.1997;53:435–52.
30.
KomanLASmithBPGoodmanA. Botulinum toxin type A in the management of cerebral palsy. Winston-Salem: Wake Forest University Press; 2002. Ref type Generic.
31.
Autti-RamoILarsenAPeltonenJTaimoAVon WeltL. Botulinum toxin injection as an adjunct when planning hand surgery in children with spastic hemiplegia. Neuropediatrics.2000;31(1):4–8.
32.
OmerGECapenDA. Proximal row carpectomy with muscle transfers for spastic paralysis. J Hand Surg.1976;1:197–204.
33.
HofferMMLehmanMMitaniM. Long-term follow-up on tendon transfers to the extensors of the wrist and fingers in patients with cerebral palsy. J Hand Surg.1986;11A:836–40.
34.
OzkanTTuncerSAydinAHosbayZGulgonenA. Brachioradialis re-routing for the restoration of active supination and correction of forearm pronation deformity in cerebral palsy. J Hand Surg Br.2004;29(3):265–70.
35.
HofferMMPerryJMelkonianGJ. Dynamic electromyography and decision-making for surgery in the upper extremity of patients with cerebral palsy. J Hand Surg.1979;4A:424–31.
36.
MoweryCAGelbermanRHRhoadesCE. Upper extremity tendon transfers in cerebral palsy: electromyographic and functional analysis. J Pediatr Orthop.1985;5:69–72.
37.
WhiteWF. Flexor muscle slide in the spastic hand: the Max Page operation. J Bone Joint Surg.1972;54B:453–9.
38.
LukbanMBRosalesRLDresslerD. Effectiveness of botulinum toxin A for upper and lower limb spasticity in children with cerebral palsy: a summary of evidence. J Neural Transm.2009;116(3):319–31.
39.
MaJShenJSmithBPRittingASmithTLKomanLA. Bioprotection of tendon repair: adjunctive use of botulinum toxin A in Achilles tendon repair in the rat. J Bone Joint Surg Am.2007;89(10):2241–9.
